Bengaluru: Air hostess pushed to death from 4th floor by techie boyfriend after fight over marriage

In a fresh claim, arrested BJP leader and advocate G Devaraje Gowda has alleged that Deputy Chief Minister D K Shivakumar and four other ministers were behind exposing Prajwal Revanna’s sex scam that has brought disgrace to Janata Dal (Secular) H D Deve Gowda family. 

Devaraje Gowda has been arrested in a sexual abuse case. 

Speaking to reporters while being taken to the district prisons, in Hassan on Friday, Gowda alleged that he was offered Rs 100 crore to drag the name of H D Kumaraswamy in the Prajwal’s case. 

“D K Shivakumar had offered me Rs 100 crore to project that H D Kumaraswamy was behind the case. The offer was made through ministers N Chaluvarayaswamy, Krishna Byre Gowda, Priyank Kharge and another minister. They had even sent Rs 5 crore as advance to Bowring Club. But I did not agree. Hence, they hatched a plot to trap me,” Gowda alleged.

“It is D K Shivakumar, who collected all information from Prajwal Revanna’s former car driver Karthik and readied the pen drive. A team of four ministers were formed to handle the issue. As I did not agree to the plan. They planned to bring disrepute to the BJP, Narendra Modi and H D Kumaraswamy,” he said.

Gowda further alleged that former MLC M A Gopalaswamy of Channarayapatna was sent to him for negotiation.

“The main intention of D K Shivakumar is to bring disrepute to Modi and BJP in the case. Besides, he wanted to defame H D Kumaraswamy’s leadership in the state” he claimed. “They filed a sexual harassment and rape case against me, but found no evidence. Now, they are trying to fix me in the pen drive case” he alleged.

A senior UN official says around 800,000 people have been "forced to flee" Rafah in the southern Gaza Strip since the Israeli regime began carrying out ground incursions into the refugee-packed city from various axes.

Philippe Lazzarini, the head of UNRWA, the UN agency for Palestinian refugees, made the remarks in a post on X, former Twitter, on Saturday.

"Nearly half of the population of Rafah or 800,000 people are on the road having been forced to flee since the Israeli forces started the military operation in the area on May 6," he said.

The invasion of the city came amid a genocidal war against Gaza by the regime that has so far claimed the lives of more than 35,300 Palestinians.

Around 1.5 million Palestinians had taken refuge in Rafah prior to the incursions, having fled there from the ravages of the war that began following a retaliatory operation against the occupied territories by Gaza’s resistance groups.

The Gazans, who have now left the city, have fled to "the middle areas and [the southern Gaza city of] Khan Younis, including to destroyed buildings," Lazzarini said.

Al-Mawasi, a 14-square-kilometer town on the coast, as well as the central city of Deir el-Balah, were "crammed" with recently displaced people, he added.

"Every time, they are forced to leave behind the few belongings they have ....Every time, they have to start from scratch, all over again."

The Israeli military has, meanwhile, seized the Rafah crossing in southern Gaza, which borders Egypt and serves as the main point of entry for aid supplies, including fuel, into Palestinian territory.

The move came as part of an all-out siege that the regime has been enforcing against the entire Gaza simultaneously with the war.

AstraZeneca said on Tuesday it had initiated the worldwide withdrawal of its COVID-19 vaccine due to a "surplus of available updated vaccines" since the pandemic.

The company also said it would proceed to withdraw the vaccine Vaxzevria's marketing authorizations within Europe.

"As multiple, variant Covid-19 vaccines have since been developed there is a surplus of available updated vaccines," the company said, adding that this had led to a decline in demand for Vaxzevria, which is no longer being manufactured or supplied.

According to media reports, the Anglo-Swedish drugmaker has previously admitted in court documents that the vaccine causes side-effects such as blood clots and low blood platelet counts.

The firm's application to withdraw the vaccine was made on March 5 and came into effect on May 7, according to the Telegraph, which first reported the development.

London-listed AstraZeneca began moving into respiratory syncytial virus vaccines and obesity drugs through several deals last year after a slowdown in growth as COVID-19 medicine sales declined.